Phibro Animal Health | PAHC - Operating Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Phibro Animal Health

Phibro Animal Health reported $227.12M in Operating Expenses for its fiscal quarter ending in March of 2023.


Operating Expenses Change
Align Technology ALGN:US USD 809.63M 20.78M
ANI Pharmaceuticals ANIP:US USD 96.89M 4.48M
Bristol-Myers Squibb BMY:US USD 8.24B 1.22B
Corcept Therapeutics CORT:US USD 90.8M 10.24M
Depomed DEPO:US USD 37.82M 1.91M
Eli Lilly LLY:US USD 5.47B 600K
Endo International ENDP:US USD 511.81M 280.86M
Henry Schein HSIC:US USD 2.88B 414M
Idexx Laboratories IDXX:US USD 619.8M 17.76M
Knight Therapeutics Inc GUD:CN CAD 76.24M 35.72M
Merck & Co MRK:US USD 10.76B 371M
Nektar Therapeutics NKTR:US USD 156.3M 81.81M
Pacira PCRX:US USD 180.36M 1.49M
Patterson Companies PDCO:US USD 1.52B 41.18M
Phibro Animal Health PAHC:US USD 227.12M 1.68M
Supernus Pharmaceuticals SUPN:US USD 148.59M 15.59M
Zoetis ZTS:US USD 1.3B 145M